Emma Copland

2.0k total citations
15 papers, 248 citations indexed

About

Emma Copland is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Oncology. According to data from OpenAlex, Emma Copland has authored 15 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Emma Copland's work include Blood Pressure and Hypertension Studies (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Hormonal Regulation and Hypertension (3 papers). Emma Copland is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Hormonal Regulation and Hypertension (3 papers). Emma Copland collaborates with scholars based in United Kingdom, Australia and United States. Emma Copland's co-authors include Milad Nazarzadeh, Kazem Rahimi, Dexter Canoy, Zeinab Bidel, Yikuan Li, Carl J. Pepine, John Chalmers, Koon Teo, Barry R. Davis and Johan Sundström and has published in prestigious journals such as The Lancet, Nature Communications and Scientific Reports.

In The Last Decade

Emma Copland

15 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Copland United Kingdom 7 137 56 29 28 20 15 248
Gurpreet Johal United States 10 108 0.8× 65 1.2× 9 0.3× 26 0.9× 32 1.6× 30 274
Jay Ariyawansa United States 10 211 1.5× 38 0.7× 14 0.5× 53 1.9× 15 0.8× 22 361
M.Á. Prieto Díaz Spain 10 169 1.2× 57 1.0× 13 0.4× 56 2.0× 25 1.3× 30 276
Timothy Doulton United Kingdom 7 157 1.1× 80 1.4× 14 0.5× 28 1.0× 10 0.5× 13 312
Andrew Lawrence United States 5 294 2.1× 57 1.0× 22 0.8× 101 3.6× 8 0.4× 8 435
John S Dowden Australia 4 191 1.4× 38 0.7× 13 0.4× 56 2.0× 29 1.4× 13 310
Ali Albasri United Kingdom 9 98 0.7× 18 0.3× 6 0.2× 36 1.3× 20 1.0× 11 279
Tina Rydén‐Bergsten Sweden 7 114 0.8× 66 1.2× 14 0.5× 70 2.5× 8 0.4× 12 220
Kota Vidyasagar India 10 33 0.2× 43 0.8× 26 0.9× 27 1.0× 19 0.9× 20 228
Hongyun Ruan China 5 119 0.9× 43 0.8× 26 0.9× 33 1.2× 83 4.2× 15 398

Countries citing papers authored by Emma Copland

Since Specialization
Citations

This map shows the geographic impact of Emma Copland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Copland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Copland more than expected).

Fields of papers citing papers by Emma Copland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Copland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Copland. The network helps show where Emma Copland may publish in the future.

Co-authorship network of co-authors of Emma Copland

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Copland. A scholar is included among the top collaborators of Emma Copland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Copland. Emma Copland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nazarzadeh, Milad, Emma Copland, Karl Smith-Byrne, et al.. (2025). Blood Pressure Lowering and Risk of Cancer. JACC CardioOncology. 7(5). 609–623. 1 indexed citations
2.
Copland, Emma, Martina Patone, Defne Saatci, et al.. (2024). Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nature Communications. 15(1). 3822–3822. 19 indexed citations
4.
Copland, Emma, Jennifer Hirst, Emma Mi, et al.. (2024). Effectiveness and safety of COVID-19 vaccination in people with blood cancer. European Journal of Cancer. 201. 113603–113603. 2 indexed citations
5.
Hirst, Jennifer, Emma Mi, Emma Copland, et al.. (2023). Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England. European Journal of Cancer. 183. 162–170. 4 indexed citations
6.
Bidel, Zeinab, Milad Nazarzadeh, Dexter Canoy, et al.. (2023). Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis. Hypertension. 80(11). 2293–2302. 11 indexed citations
7.
Wamil, Małgorzata, Abdelǎali Hassaïne, Shishir Rao, et al.. (2023). Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis. Scientific Reports. 13(1). 11478–11478. 2 indexed citations
8.
Canoy, Dexter, Milad Nazarzadeh, Emma Copland, et al.. (2022). How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?. Current Cardiology Reports. 24(7). 851–860. 57 indexed citations
9.
Nazarzadeh, Milad, Dexter Canoy, Zeinab Bidel, et al.. (2022). The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports. Journal of Hypertension. 40(5). 847–852. 5 indexed citations
10.
Nazarzadeh, Milad, Zeinab Bidel, Dexter Canoy, et al.. (2021). Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. The Lancet. 398(10313). 1803–1810. 71 indexed citations
11.
Pinho‐Gomes, Ana‐Catarina, Luís Filipe Azevedo, Emma Copland, et al.. (2021). Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis. PLoS Medicine. 18(6). e1003599–e1003599. 20 indexed citations
12.
Pinho‐Gomes, Ana‐Catarina, Luís Filipe Azevedo, Emma Copland, et al.. (2020). Blood pressure lowering treatment for prevention of cardiovascular events in patients with atrial fibrillation: an individual-participant data meta-analysis. European Heart Journal. 41(Supplement_2). 1 indexed citations
13.
Pinho‐Gomes, Ana‐Catarina, Luís Filipe Azevedo, Zeinab Bidel, et al.. (2019). Effects of blood pressure-lowering drugs in heart failure. Journal of Hypertension. 37(9). 1757–1767. 6 indexed citations
14.
Solares, José Roberto Ayala, Dexter Canoy, Francesca Raimondi, et al.. (2019). Long‐Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large‐Scale Routine Electronic Health Records. Journal of the American Heart Association. 8(12). e012129–e012129. 31 indexed citations
15.
Copland, Emma, et al.. (2016). A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in England. Journal of Ect. 33(3). 198–202. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026